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Abstract
Objective
To investigate whether indices of obesity are associated with insulin resistance in Korean
adolescents.
Methods
This study was conducted as a cross-sectional analysis of 817 healthy adolescents aged
15–16 years without diabetes. Percentiles group of weight-for-height, body mass index
(BMI)-for-age, waist circumference (WC)-for-age, and skin fold thickness (SFT)-for-age
were based on the 2007 Korean National Growth Charts. Percentiles of waist-to-hip ratio
(WHR), waist-to-height ratio (WHtR), and percent body fat were calculated for the study
population. Insulin resistance was estimated by homeostatic model assessment (HOMA-
IR). Logistic regression models were used to estimate odds ratio for insulin resistance
according to seven obesity indices. Generalized linear models were used to assess the as-
sociations between obesity indices and continuous HOMA-IR levels.
Results
Sex and age-adjusted odds ratios (95% confidence interval) for insulin resistance, defined
as HOMA-IR>2.50, of the 75–94th and95th percentiles of weight-for-height were 3.87
(2.38–6.30) and 11.37 (5.87–22.02), compared to the <50th percentile. Corresponding
odds ratios were 3.27 (2.02–5.28) and 11.72 (6.05–22.73) for BMI-for-age, 4.72 (2.82–7.88)
and 13.22 (6.42–27.23) for WC-for-age, 3.67 (2.27–5.94) and 13.58 (6.71–27.48) for WHR,
4.78 (2.99–7.67) and 12.84 (6.23–26.46) for WHtR, 2.62 (1.61–4.26) and 6.68 (3.46–12.90)
for SFT-for-age, and 2.29 (1.33–4.26) and 10.06 (4.39–23.06) for body fat. These associa-
tions were more prominent when insulin resistance was defined as HOMA-IR>3.16 and
were stronger in males than in females. Continuous measure of HOMA-IR was significantly
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associated with body weight, BMI, WC, WHR, WHtR, and SFT in both sexes (p<0.001), and
with percent body fat in males only (p<0.001).
Conclusion
Our findings suggest that obesity indices are positively associated with insulin resistance in
apparently healthy adolescents.
Introduction
Obesity is a growing concern worldwide. The prevalence of childhood obesity has more than
doubled in the last two decades [1]. The epidemic status of obesity is associated with an in-
creasing number of children and adolescents with type 2 diabetes [2]. Overweight and obesity
are important risk factors of type 2 diabetes; they have been shown to be associated with insulin
resistance in persons with normal glucose level [3]. As well, an inverse linear association be-
tween body mass index (BMI) and age at diagnosis of type 2 diabetes has been reported [4],
spurring interest as to whether abnormal glucose metabolism can be detected at an early age.
In previous studies increased risk for insulin resistance was noted for adolescents with promi-
nent obesity [5, 6]. The association between obesity and insulin resistance was also reported in
Korean patients with hyperlipidemia and middle-aged Korean offspring of hypertensive pa-
rents [7, 8]. Meanwhile, data on whether being overweight is associated with insulin resistance
in healthy adolescents are lacking. In this study, we investigated the association between vari-
ous indices of obesity and insulin resistance as measured by HOMA-IR in a healthy Korean
adolescent population.
Materials and Methods
Study participants
This study was conducted as a cross-sectional analysis of baseline data collected for cohort
study. Health examinations and questionnaire were administered to all first-year students at a
rural high school throughout April 2007, June 2010, and June 2011. Of the 852 available first-
year students (287 in 2007, 282 in 2010, and 283 in 2011), 817 students (278 in 2007, 275 in
2010, and 264 in 2011) aged 15–16 years who completed all physical examinations, blood labo-
ratory tests, and the self-reported questionnaire were enrolled in the study. All participants had
no previously diagnosis of diabetes mellitus or hypertension. Written informed consent was
obtained from each participant and his/her parent or guardian. Informed consent forms were
distributed to eligible students at least one week prior to the examination, allowing the partici-
pating students and their parents enough time to understand the purpose and procedures of
the study. On the day of examination, research staff checked whether each consent form was
completed and signed by the student, as well as his/her parent or guardian. The study protocol
and consent procedure was approved by the Institutional Review Board of Severance Hospital
at Yonsei University College of Medicine (Approval No. 4–20100169).
Measurements
Individual health-related lifestyles, as well as personal and family disease history, were evaluat-
ed with self-administered questionnaires. Anthropometric measurements were performed
according to a predefined protocol. Standing height was measured to the nearest 0.1 cm on a
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stadiometer. Body weight was measured to the nearest 0.1 kg on a digital scale, with the subject
wearing their school uniform. Body mass index (BMI) was calculated as weight divided by the
square of height (kg/m2). Waist circumference (WC) was measured to the nearest 0.1 cm at the
level of the superior iliac crest at the end of a normal expiration. Hip circumference was mea-
sured at the level of widest circumference over the greater trochanters. Waist-to-hip ratio
(WHR) was calculated as waist circumference divided by hip circumference. Waist-to-height
ratio (WHtR) was calculated as waist circumference divided by height. Each triceps and sub-
scapular skin fold thickness (SFT) was measured twice, and the average of the four measure-
ments was used for analysis. Percent body fat was measured by bioelectrical impedance
analysis in only 277 students in 2007 (GIF-891DX, Gil Woo, Korea) and in 264 students in
2011 (InBody 720, Biospace, Korea).
Systolic and diastolic blood pressures (SBP and DBP) were measured on the right arm with
an oscillometric device (Dinamap 1846 SX/P, USA). Two readings at 5 min interval were ob-
tained and averaged to determine SBP and DBP for each individual. If the two readings differed
by more than 10 mmHg, additional readings were obtained and the last two readings were av-
eraged. Smoking (male: n = 6 [1.4%] and female: n = 1 [0.3%]) and drinking (male: n = 14
[3.3%] and female: n = 9 [2.3%]) histories were obtained by self-reported questionnaires; how-
ever, they were not included in the multivariate analysis, as the small number of participants
would not have affected the final outcomes.
Fasting blood samples were drawn after at least an 8-hour fast. Serum concentrations of
total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, aspartate amino-
transferase (AST), and alanine aminotransferase (ALT) were measured by enzymatic methods
with an autoanalyzer. Fasting glucose level was measured by a glucose hexokinase method. In-
sulin level was measured on the basis of a radio-immunometric method. Insulin resistance was
assessed by the homeostatic model assessment (HOMA-IR), calculated as the product of the
fasting plasma insulin level (IU/l) and the fasting plasma glucose level (mmol/l) divided by
22.5. Insulin resistance is generally defined as a HOMA-IR>2.50 in adults [9], but a recent
study suggested a higher cut-off point>3.16 for children and adolescents [10]; thus we defined
insulin resistance using these two different cutpoints.
Statistical analysis
Sex-specific percentile values of weight-for-height, BMI-for-age, WC-for-age, and SFT-for-age
were obtained from the 2007 Korean National Growth Charts [11, 12]. Sex-specific percentile val-
ues of WHR,WHtR, and percent body fat were based on their distribution in the study popula-
tion, because they were not available in the growth chart. Participants were classified into four
groups according to percentiles (<50th, 50–74th, 75–94th, and95th percentiles) according to
the seven obesity indices. Distributions of cardiovascular and metabolic risk factors were deter-
mined for these four groups, and their linear trends were tested. Associations between weight-for-
height percentiles and metabolic abnormalities were assessed using logistic regression models.
Metabolic abnormalities in these analyses included high blood pressure (SBP120 mmHg or
DBP80 mmHg), high total cholesterol (200 mg/dl), high triglycerides (150mg/dl), elevated
liver enzymes (AST30 IU/l or ALT30 IU/l), high fasting glucose (100 mg/dl), and high
HOMA-IR (>2.50 and>3.16). Odds ratios and 95% confidence interval (CI) for each metabolic
abnormality were obtained for the 50–74th, 75–94th, and95 percentiles groups, compared to the
lowest (<50th percentile) weight-for-height group. Sex and age-adjusted odds ratios (95% CI) for
insulin resistance were also estimated according to the percentiles for the other obesity indices
(BMI-for-age, WC-for-age, WHR,WHtR, SFT-for-age, and percent body fat). Insulin resistance
was defined using two different cut-offs for HOMA-IR:>2.50 and>3.16. Obesity indices were
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analysed as categorical variables (<50th, 50–74th, 75–94th, and95 percentiles) as well as continu-
ous variables (per one standard deviation increase). Finally, associations of the seven obesity indi-
ces and HOMA-IR levels were assessed using generalized linear models separately for males and
females after adjustment for age. Means of HOMA-IR were calculated by the least-squares meth-
od for four percentile groups of weight-for-height, BMI-for-age, WC-for-age, WHR,WHtR, SFT-
for-age, and percent body fat. Incremental HOMA-IR value was also calculated per one SD in-
crease of body weight, BMI,WC,WHR,WHtR, SFT, and percent body fat. All statistical analyses
were two-tailed and performed using SAS software version 9.1 (SAS Institute, Cary, NC, USA).
All P-values<0.05 ware considered statistically significant.
Results
The characteristics of the 817 (418 male and 399 female) participants are shown in Table 1. Al-
though study participants were recruited from a single high school, their anthropometric and
blood pressure distributions were similar to those in the 2007 Korean National Growth Charts.
The median height was 171.4 /159.5 cm (male/female) in this study, and the corresponding
value from the growth charts was 170.3/159.6 cm. The median body weight was 63.4/53.3 kg
(male/female) in this study and 60.1/53.1 kg in the growth charts. None of the adolescents had
a fasting glucose higher than 110 mg/dl. Only seven adolescents (0.9%) were current smokers,
and 23 (2.8%) consumed alcoholic drinks at least once a month.
According to an increase in weight-for-height percentile, body weight, BMI, WC, WHR,
WHtR, SFT, body fat, SBP, triglyceride, total/HDL-cholesterol ratio, ALT, fasting glucose, fast-
ing insulin, and HOMA-IR levels increased, while HDL-cholesterol level decreased. Age,
height, DBP, total cholesterol, and AST levels were not significantly associated with weight-
for-height percentile groups (Table 2).
When compared to adolescents with lower weight-for-height (<50th percentile), those in
the 50–74th percentiles exhibited an increased risk for only high blood pressure (p = 0.003).
Adolescents in the 75–94th weight-for-height percentile were at increased risks for high blood
pressure (p<0.001), hypertriglyceridemia (p = 0.029), and insulin resistance (p<0.001). Ado-
lescents in the95th weight-for-height percentile showed increased risks for high blood pres-
sure (p<0.001), hypercholesterolemia (p = 0.042), hypertriglyceridemia (p = 0.002), elevated
liver enzyme (p<0.001), and insulin resistance (p<0.001) (Table 3).
All seven indices of obesity had significant positive associations with insulin resistance.
These associations were consistent in analyses with categorical variables based on the growth
charts percentiles and in analyses with continuous scales of weight-for-height, BMI-for-age,
WC-for-age, WHR, WHtR, SFT-for-age, and percent body fat. Among the seven obesity indi-
ces, waist circumference (both in percentile groups and in continuous measure) showed the
strongest association with risk for having insulin resistance (Table 4).
Fig 1 displays the association between obesity indices and HOMA-IR separately for male and
female adolescents. In males, mean HOMA-IR levels were strongly and positively associated with
percentile groups of weight-for-height, BMI-for-age, WC-for-age, WHR,WHtR, SFT-for-age,
and percent body fat (p<0.001 for all). Similar significant associations were observed also in fe-
males, although the strength of the associations was weaker than in males. Incremental
HOMA-IR values related to one standard deviation increase of obesity indices was the highest
for BMI (β = 0.38; p<0.001) andWHtR (β = 0.37; p<0.001) in male adolescents. In females ado-
lescents, WHtR (β = 0.26; p<0.001), WC (β = 0.24; p<0.001), andWHR (β = 022; p<0.001)
were associated with incremental increases in HOMA-IR. However, continuous measure of per-
cent body fat was not associated with HOMA-IR in female adolescents (β = −0.01; p = 0.751).
Obesity Indices and Insulin Resistance among Healthy Adolescents
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Raw data used to create Fig 1 can be found in S1 and S2 Tables. More results from sex-specific
analysis are also available in S3 and S4 Tables.
Discussion
We observed that insulin resistance (measured by HOMA-IR), which is known to increase the
risk of developing diabetes, is closely associated with obesity indices in apparently healthy ado-
lescents. All seven indices of obesity (weight, BMI, WC, WHR, WHtR, SFT, body fat) exhibited
significant positive associations with insulin resistance. A stronger association between
HOMA-IR levels and obesity indices was noted in males than in females.
Insulin resistance accompanying obesity is known to play a key role in diabetes develop-
ment. In the Bogalusa Heart Study, adverse levels and acceleration of metabolic risk variables,
Table 1. Characteristics of Study Participants.
Variables Total (n = 817) Male (n = 418) Female (n = 399) p
Age, year 15.8 ± 0.3 15.8 ± 0.3 15.8 ± 0.3 0.989
Height, cm 165.7 ± 7.8 171.4 ± 5.4 159.7 ± 5.0 <.001
Weight, kg 59.7 ± 10.8 65.1 ± 10.8 54.0 ± 7.3 <.001
BMI, kg/m2 21.7 ± 3.0 22.1 ± 3.3 21.1 ± 2.6 <.001
WC, cm 73.6 ± 7.7 75.3 ± 8.4 71.9 ± 6.6 <.001
WHR 0.78 ± 0.05 0.80 ± 0.05 0.77 ± 0.04 <.001
WHtR 0.44 ± 0.04 0.44 ± 0.05 0.45 ± 0.04 <.001
SFT, cm 16.1 ± 6.2 13.5 ± 5.7 18.9 ± 5.4 <.001
Percent body fat* 21.4 ± 7.7 16.6 ± 6.3 26.4 ± 5.5 <.001
SBP, mmHg 108 ± 12 113 ± 12 103 ± 11 <.001
DBP, mmHg 59 ± 7 60 ± 7 59 ± 7 0.421
Total cholesterol, mg/dl 154 ± 26 148 ± 26 161 ± 25 <.001
HDL cholesterol, mg/dl 44 ± 9 41 ± 8 47 ± 9 <.001
Triglycerides, mg/dl 81 ± 29 83 ± 31 78 ± 27 0.015
Total/HDL-cholesterol ratio 3.59 ± 0.77 3.68 ± 0.82 3.49 ± 0.71 <.001
AST, IU/l 20 ± 6 22 ± 4 18 ± 3 <.001
ALT, IU/l 16 ± 10 19 ± 12 13 ± 5 <.001
Fasting glucose, mg/dl 88 ± 7 90 ± 7 87 ± 7 <.001
Fasting insulin, uIU/mL 8.7 ± 3.2 8.7 ± 3.4 8.7 ± 2.9 0.867
HOMA-IR 1.91 ± 0.79 1.94 ± 0.86 1.87 ± 0.70 0.229
Weight-for-height 95 percentile 51 (6.2%) 26 (6.2%) 25 (6.3%) 0.367
BMI-for-age 95 percentile 50 (6.1%) 28 (6.7%) 22 (5.5%) 0.464
WC-for-age 95 percentile 45 (5.5%) 15 (3.6%) 30 (7.5%) <.001
SFT-for-age 95 percentile 53 (6.5%) 18 (4.3%) 35 (8.8%) 0.067
WHR 95 percentile 42 (5.1%) 21 (5.0%) 21 (5.3%) 0.999
WHtR 95 percentile 39 (4.8%) 20 (4.8%) 19 (4.8%) 0.999
Percent body fat 95 percentile 29 (5.4%) 15 (5.4%) 14 (5.3%) 0.999
Ever smoker 100 cigarette 7 (0.9%) 6 (1.4%) 1 (0.3%) 0.145
Alcohol intake 1/month 23 (2.8%) 14 (3.3%) 9 (2.3%) 0.345
Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; SFT, skin-fold thickness; SBP,
systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HOMA-IR, Homeostasis model
assessment insulin resistance.
Data are expressed as mean ± SD or number (%)
*Percent body fat was measured in 541 adolescents (277 males and 264 females).
doi:10.1371/journal.pone.0125238.t001
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adiposity, and HOMA-IR during childhood and adolescents were closely associated with later
onset of diabetes [13]. Interestingly, obesity beginning in childhood has been shown to not
only influence the onset of type 2 diabetes but also be the most consistent predictor of adverse
changes leading to diabetes, regardless of age, race, or sex. The mechanisms of developing im-
paired glucose regulation and diabetes may be similar between adults and adolescents; howev-
er, it is uncertain when and which factors contribute to insulin resistance in adolescents as
different metabolic risk factors can attribute to the development of insulin resistance in differ-
ent age groups. In a prospective study of both children and adolescents, the most significant
predictor of diabetes was WC in 5- to 9-year-olds; 2-hour glucose, BMI and HbA1c in 10- to
14–year-olds; and 2-hour glucose, WC and HbA1c in 15- to 19-year-old subjects [14]. Our
findings showed that seven obesity indices are positively associated with insulin resistance even
in apparently healthy adolescents, and that even a moderate increase (75–94th percentiles) in
obesity indices may be associated with risk of insulin resistance.
In this study, a sex-difference was discovered in the associations between obesity indices
and insulin resistance. Mean HOMA-IR levels showed positive progressive associations with
obesity indices in male adolescents. However, HOMA-IR values were not associated with per-
cent body fat in female adolescents. These findings suggest that simple anthropometric mea-
surements of general obesity, such as weight-for-height, BMI or SFT, and central obesity
Table 2. Metabolic Characteristics byWeight-for-Height Percentile.
Variable Mean (95% CI) by Weight-for-Height percentile group
<50 percentile (N = 363) 50–74 percentile (N = 228) 75–94 percentile (N = 175) 95 percentile (N = 51) p for trend*
Age, year 15.8 (15.8–15.8) 15.8 (15.8–15.9) 15.8 (15.8–15.9) 15.8 (15.7–15.9) 0.546
Height, cm 166.3 (165.6–167.1) 165.1 (164.1–166.1) 165.3 (164.0–166.6) 165.0 (162.5–167.6) 0.087
Weight, kg 53.5 (52.9–54.2) 59.5 (58.5–60.4) 67.2 (65.7–68.6) 78.8 (75.1–82.5) <.001
BMI, kg/m2 19.3 (19.2–19.4) 21.7 (21.6–21.8) 24.4 (24.2–24.7) 28.7 (28.1–29.4) <.001
WC, cm 68.7 (68.2–69.1) 73.1 (72.6–73.7) 79.9 (79.0–80.8) 89.8 (87.5–92.1) <.001
WHR 0.77 (0.76–0.77) 0.78 (0.77–0.78) 0.81 (0.81–0.82) 0.86 (0.84–0.88) <.001
WHtR 0.41 (0.41–0.42) 0.44 (0.44–0.45) 0.48(0.48–0.49) 0.54 (0.53–0.55) <.001
SFT, cm 12.8 (12.4–13.3) 16.3 (15.7–16.9) 19.4 (18.7–20.2) 27.3 (25.3–29.3) <.001
Percent body fat** 17.9 (17.1–18.7) 21.8 (20.7–22.8) 25.4 (24.1–26.6) 32.9 (30.7–35.0) <.001
SBP, mmHg 105 (104–106) 108 (107–110) 112 (110–114) 117 (113–121) <.001
DBP, mmHg 59 (59–60) 59 (58–60) 60 (59–61) 61 (59–63) 0.158
Total cholesterol, mg/dl 152 (150–155) 156 (152–159) 155 (151–159) 160 (152–168) 0.065
HDL cholesterol, mg/dl 45 (44–46) 45 (44–47) 42 (41–43) 39.6 (37–42) <.001
Triglycerides, mg/dl 77 (75–80) 79 (76–83) 87 (82–92) 95 (85–105) <.001
Total/HDL-cholesterol 3.44 (3.37–3.51) 3.52 (3.42–3.62) 3.81 (3.69–3.93) 4.19 (3.88–4.49) <.001
AST, IU/l 20 (20–21) 20 (19–20) 19 (19–20) 23 (19–27) 0.207
ALT, IU/l 15 (14–15) 15 (15–16) 17 (16–18) 29 (21–36) <.001
Fasting glucose, mg/dl 88 (87–89) 88 (87–89) 89 (88–90) 90 (88–92) 0.031
Fasting insulin, uIU/mL 7.75 (7.52–7.98) 8.41 (8.08–8.74) 9.88 (9.27–10.48) 12.25 (11.09–13.41) <.001
HOMA-IR 1.70 (1.64–1.76) 1.84 (1.76–1.92) 2.19 (2.03–2.35) 2.74 (2.46–3.03) <.001
Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; SFT, skin-fold thickness; SBP,
systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HOMA-IR, Homeostasis model
assessment insulin resistance.
*P-values are adjusted for sex and age (except for the trend of age itself).
**Percent body fat was measured in 541 adolescents (277 males and 264 females).
doi:10.1371/journal.pone.0125238.t002
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markers, such as WC, WHR, or WHtR, can predict obesity-related insulin resistance in female
adolescents better than skin fold thickness measurement or bioimpedance analysis. However,
hormonal status during puberty, especially for female adolescents, might affect the relationship
between obesity and glucose metabolism. In a study of obese children and adolescents, insulin
resistance was more common in obese adolescents at higher Tanner stages than in those at
lower Tanner stages [15]. Insulin resistance during puberty is related to increases in growth
hormone levels due to increasing lipolysis and free fatty acid concentrations. The growth hor-
mone/insulin-like growth factor-I axis contributes to the transient physiological rise in insulin
resistance during normal puberty [16, 17]. The growth hormone/insulin-like growth factor-I
axis and insulin resistance are involved in the mechanism of adrenarche during prepuberty
[18], and insulin resistance reaches its peak during mid-puberty [19]. Insulin sensitivity during
normal pre-pubertal and pubertal development differs between males and females. Although
the reasons for the sex-differences remain unclear, there are three distinctive differences be-
tween males and females that influence the association with insulin resistance; First, females
are ahead of males in their physical and sexual development and reach Tanner stages IV-V ear-
lier than males. Second, body fat mass and body fat distribution differ between male and female
adolescents [20]. Third, sex hormones during puberty such as oestrogen may influence insulin
resistance; a rise in oestrogen level in females may enhance insulin sensitivity due to its role in
suppressing secretion of glucagons and protecting against pancreatic insulin responses to glu-
cose [21]. These differences in development and hormonal status between males and females
can explain, at least in part, the noted sex difference in the associations between obesity indices
and insulin resistance.
Associations between obesity indices and insulin resistance or type 2 diabetes are established
in adult populations [3, 22]. Our study showed that various obesity indices are strongly and
progressively associated with insulin resistance in a healthy Korean adolescent population. As
Table 3. Risk for Metabolic Abnormalities byWeight-for-Height Percentile.
Dependent variables (metabolic abnormality) Odds ratio (95% CI) by Weight-for-Height percentile group
<50 percentile 50–74 percentile 75–94 percentile 95 percentile
Unadjusted
SBP/DBP 120/80 mmHg 1.00 2.04 (1.18–3.54) 4.35 (2.58–7.36) 7.70 (3.85–15.40)
Total cholesterol 200 mg/dl 1.00 1.31 (0.62–2.78) 1.18 (0.51–2.72) 2.89 (1.08–7.77)
Triglycerides 150 mg/dl 1.00 1.94 (0.58–6.42) 3.43 (1.11–10.64) 7.79 (2.17–27.92)
AST or ALT 30 IU/l 1.00 0.91 (0.37–2.20) 1.84 (0.83–4.06) 7.67 (3.31–17.75)
Fasting glucose 100 mg/dl 1.00 1.11 (0.47–2.63) 1.63 (0.70–3.80) 1.68 (0.46–6.12)
HOMA-IR >2.50 1.00 1.36 (0.80–2.30) 3.76 (2.32–6.10) 10.88 (5.66–20.92)
HOMA-IR >3.16 1.00 2.14 (0.48–9.66) 14.62 (4.26–50.11) 50.00 (13.82–180.9)
Adjusted for sex and age
SBP/DBP 120/80 mmHg 1.00 2.40 (1.36–4.24) 5.11 (2.95–8.85) 10.08 (4.75–21.39)
Total cholesterol 200 mg/dl 1.00 1.20 (0.56–2.56) 1.13 (0.49–2.63) 2.83 (1.04–7.71)
Triglycerides 150 mg/dl 1.00 2.06 (0.62–6.86) 3.56 (1.14–11.08) 8.07 (2.23–29.22)
AST or ALT 30 IU/l 1.00 1.02 (0.42–2.49) 1.96 (0.88–4.39) 9.37 (3.86–22.75)
Fasting glucose 100 mg/dl 1.00 1.21 (0.50–2.89) 1.69 (0.72–3.95) 1.74 (0.47–6.39)
HOMA-IR >2.50 1.00 1.39 (0.81–2.36) 3.87 (2.38–6.30) 11.37 (5.87–22.02)
HOMA-IR >3.16 1.00 2.20 (0.49–9.94) 14.80 (4.31–50.76) 51.01 (14.07–185.0)
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HOMA-IR,
Homeostasis model assessment insulin resistance.
doi:10.1371/journal.pone.0125238.t003
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Table 4. Risk for Insulin Resistance by Different Obesity Indices.
Independent variable (obesity index) HOMA-IR >2.50 HOMA-IR >3.16
No. of people No. Odds ratio (95% CI)* No. Odds ratio (95% CI) *
Weight-for-height percentile
<50 363 34 1.00 3 1.00
50–74 228 28 1.39 (0.81–2.36) 4 2.20 (0.49–9.94)
75–94 175 49 3.87 (2.38–6.30) 19 14.80 (4.31–50.76)
95 51 27 11.37 (5.87–22.02) 15 51.01 (14.07–185.0)
BMI-for-age percentile
<50 360 36 1.00 4 1.00
50–74 225 26 1.18 (0.69–2.01) 5 2.02 (0.54–7.62)
75–94 182 48 3.27 (2.02–5.28) 16 8.48 (2.79–25.78)
95 50 28 11.72 (6.05–22.73) 16 41.52 (13.13–131.3)
WC-for-age percentile
<50 333 28 1.00 2 1.00
50–74 255 34 1.73 (1.02–2.95) 7 5.07 (1.04–24.65)
75–94 184 53 4.72 (2.82–7.88) 21 25.85 (5.93–112.75)
95 45 23 13.22 (6.42–27.23) 11 70.01 (14.54–337.0)
WHR percentile
<50 407 38 1.00 5 1.00
50–74 205 30 1.68 (1.01–2.81) 8 3.25 (1.05–10.06)
75–94 163 45 3.67 (2.27–5.94) 17 9.51 (3.44–26.28)
95 42 25 13.58 (6.71–27.48) 11 30.92 (9.95–96.04)
WHtR percentile
<50 408 38 1.00 2 1.00
50–74 205 25 1.39 (0.81–2.37) 8 8.25 (1.74–39.25)
75–94 165 53 4.78 (2.99–7.67) 20 28.04 (6.47–121.49)
95 39 22 12.84 (6.23 + 26. 46) 11 80.45 (16.97–381.29)
SFT-for-age percentile
<50 354 39 1.00 5 1.00
50–74 238 35 1.49 (0.91–2.45) 8 2.49 (0.80–7.72)
75–94 171 41 2.62 (1.61–4.26) 17 7.88 (2.85–21.77)
95 53 22 6.68 (3.46–12.90) 11 21.04 (6.82–64.88)
Percent body fat percentile**
<50 266 37 1.00 7 1.00
50–74 136 29 1.66 (0.97–2.84) 6 1.73 (0.57–5.27)
75–94 110 30 2.29 (1.33–3.96) 10 3.76 (1.39–10.18)
95 29 18 10.06 (4.39–23.06) 10 20.06 (6.83–58.95)
One SD increase in
Body weight 817 138 1.93 (1.61–2.32) 41 2.74 (2.06–3.64)
BMI 817 138 2.14 (1.78–2.57) 41 3.08 (2.30–4.13)
WC 817 138 2.23 (1.85–2.68) 41 3.29 (2.45–4.44)
WHR 817 138 2.16 (1.78–2.63) 41 2.98 (2.18–4.08)
WHtR 817 138 2.31 (1.91–2.80) 41 3.31 (2.46–4.46)
SFT 816 137 1.81 (1.52–2.16) 41 2.45 (1.88–3.18)
Percent body fat 541 114 1.59 (1.29–1.95) 33 2.15 (1.56–2.96)
Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; SFT, skin-fold thickness; HOMA-IR,
Homeostasis model assessment insulin resistance.
*Odds ratios were adjusted for sex and age.
**Percent body fat was measured in 541 adolescents (277 males and 264 females).
doi:10.1371/journal.pone.0125238.t004
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this study population includes non-diabetic adolescents, as well as very few smokers and alco-
hol drinkers, it would be unlikely that the association between obesity and insulin resistance
would be confounded by other factors. Insulin resistance is generally defined as a HOMA-IR
>2.50 in adults, although a cut-off is not established for children and adolescents. In this study
we used two different cut-offs (HOMA-IR>2.50 and>3.16). Although the nature of associa-
tions between obesity and insulin resistance are similar for both cut-off points, the odds ratio
was greater when we used the higher cut-off (HOMA-IR>3.16). This finding is consistent
with a previous study suggesting a higher cut-off>3.16 for children and adolescents [10]. In
our study population, adolescents with higher obesity indices had markedly increased odds for
having insulin resistance, although their fasting glucose levels were normal and not associated
with obesity indices. This finding is partially in line with previous studies in which anthropo-
metric indexes were not found to be associated with fasting glucose levels in children and ado-
lescents [23, 24].
Fig 1. HOMA-IR Levels according to Different Obesity Indices in Male and Female Adolescents. Abbreviations: HOMA-IR, Homeostasis model
assessment insulin resistance; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; SFT, skin-fold
thickness. Percent body fat was measured for 541 adolescents (277 males and 264 females). Upper panel shows age-adjusted mean HOMA-IR values by
percentile groups for weight-for-height, BMI-for-age, WC-for-age, WHR,WHtR, SFT-for-age, and percent body fat in male and female adolescents. Lower
panel shows age-adjusted incremental HOMA-IR per one standard deviation increase in body weight, BMI, WC, WHR, WHtR, SFT and percent body fat in
male and female adolescents.
doi:10.1371/journal.pone.0125238.g001
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This study has several limitations. First, insulin resistance was not measured by direct meth-
ods, such as glucose clamp or frequently sampled intravenous glucose tolerance test. However,
HOMA-IR has been reported to be a reliable measure of insulin resistance in children and
adolescents [9, 25]. Second, this study comprised a relatively small sample size of which the
participants were homogenous. Thus, it may not be large enough to detect differences in the as-
sociation of various obesity indices or differences between males and females. Third, most
study participants were in the midst of puberty, a period when hormonal status may influence
the indices of obesity, as well as insulin sensitivity. Female adolescents enter puberty earlier
and have more fat mass, and these differences can act as confounding factors when comparing
sexes. Moreover, physiological insulin resistance during puberty cannot be distinguished from
insulin resistance arising from obesity [26].
In conclusion, this study suggests that moderate overweight or obesity is positively associat-
ed with higher insulin resistance in healthy adolescents. Simple anthropometric measurements
and their comparison to standard growth charts can identify adolescents at higher risk for insu-
lin resistance or diabetes. Regular screening with anthropometric measurements at schools
should be enforced, as adolescents would be expected to benefit from screening strategies and
early intervention. Our findings suggested that HOMA-IR, which is a validated surrogate
marker of insulin resistance, should be used instead of fasting plasma glucose level to identify
high-risk adolescents and to prevent them from developing diabetes. Further prospective stud-
ies are required to evaluate whether weight control in adolescents actually improves insulin
sensitivity and prevents the onset of diabetes.
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